This blended lyophilized preparation combines two well-characterized research peptides frequently studied for their complementary activity within growth-hormone–related pathways.
CJC-1295 (Modified GRF 1-29) is a synthetic growth-hormone–releasing hormone (GHRH) analog used in research to investigate extended receptor engagement and amplified pulsatile signaling. Laboratory models assess its interactions with pituitary GHRH receptors and its potential to modulate downstream cellular pathways related to anabolic signaling and tissue regeneration.
Ipamorelin is a highly selective pentapeptide secretagogue used in studies exploring ghrelin-receptor binding and growth-hormone axis regulation. Its receptor specificity makes it a preferred tool for experiments requiring minimal off-target endocrine interference.
When combined in controlled research settings, the blend enables investigators to study dual-pathway stimulation—the GHRH receptor (CJC-1295) and the ghrelin/secretagogue receptor (Ipamorelin)—allowing exploration of synergistic patterns in pulsatile GH signaling, receptor crosstalk, and endocrine axis behavior.
Synergistic Characteristics of the CJC-1295 + Ipamorelin Blend:
- Dual-receptor pathway activation (GHRH + ghrelin receptor)
- Enhanced modeling of pulsatile secretion patterns
- Ability to study baseline vs. peak GH-axis activity
- Useful for investigating additive or synergistic endocrine interactions
- Supports evaluation of long-duration vs. rapid-onset secretagogue effects
- Provides researchers with a controlled model of multi-pathway signaling dynamics
Primary Research Areas
- Pituitary GHRH-receptor signaling pathways
- Ghrelin-receptor activation and downstream transcriptional effects
- Growth-hormone pulse modeling and pulsatility analysis
- Cellular studies on endocrine-axis regulation
- Anabolic-signaling investigations in preclinical models
- Tissue-repair and regenerative-biology research
- Comparative studies of single-agent vs. dual-pathway stimulation
- Receptor crosstalk and secretagogue synergy mapping
CJC1295/Ipamorelin Structure:
CJC 1295 Molecular Formula: C152H252N44O42
CJC 1295 Molecular Weight: 3367.95 g/mol
CJC 1295 CAS Number: 863288-34-0
CJC 1295 PubChem ID: 56841945
Ipamorelin Molecular Formula: C38 H49 N9 O5
Ipamorelin Molecular Weight: 711.85 g/mol
Ipamorelin CAS Number: 170851-70-4
Ipamorelin PubChem ID: 9831659
